“Nations have spent decades and billions of dollars to try and uncover the mysteries of biology to advance healthcare. Just like volunteering to be an organ donor on your driver’s license is a simple act of service with a profound impact, the Truveta Genome Project enables each of us to anonymously contribute to dramatically accelerate progress in discovering the science of humanity, improving the health of our families and communities, and lowering the cost of care. Discoveries from smaller datasets before today’s AI have led to important new approaches to help prevent heart disease and restore hearing in children with certain forms of congenital deafness – it is so exciting to envision where a complete representative genomic dataset will guide us.”

“As health system leaders, we aspire to protect and care for the health of our communities – not treat diseases once they are already afflicted,” said Michael Dowling, Northwell Heath CEO. “The Truveta Genome Project has the potential to transform healthcare from treating disease to preventing disease, and we are excited to make it happen.”

“The integration of genomics with the rich clinical data in Truveta has the potential to revolutionize patient care. By analyzing genetic information alongside clinical and environmental data, we can uncover how different populations are uniquely affected by their environments and develop targeted interventions to reduce health disparities. This approach ensures that all patients receive the most effective and personalized care. Together, we are paving the way for a more equitable and inclusive future in healthcare.”